Victoza Pancreatic Cancer

Victoza Pancreatic Cancer
The Type 2 diabetes drug Victoza may be associated with an increased risk of pancreatic cancer. A devastating disease, 95% of those diagnosed with pancreatic cancer will survive less than five years.

Legal Help for Victims of Victoza and Pancreatic Cancer

Victoza users who were diagnosed with pancreatic cancer, as well as their surviving family members, may be entitled to compensation for their pain and suffering. To learn more about filing a Victoza lawsuit, please contact the nationwide law firm of Bernstein Liebhard LLP at (888) 994-5118.

Studies Linking Victoza to Pancreatic Cancer

Victoza belongs to a class of Type 2 diabetes drugs called incretin mimetics. Some studies have suggested that medications in this class may increase a patient’s risk for pancreatic cancer.

  • March 2013: A study that appeared in Diabetes found precancerous changes in the pancreatic cells of autopsied patients who had been treated with incretin mimetics for at least a year. Adenomas, benign tumors that can become malignant, were found in some of the pancreases.
  • June 2013: An investigation by the British Medical Journal concluded that the pancreatic risks associated with Victoza and other incretin mimetics may have been downplayed by the pharmaceutical industry. Read More
  • Between February 2010 and September 2011, the consumer advocacy group Public Citizen found 28 reports of pancreatic cancer among Victoza patients. Just a single case of the disease was reported among people taking alternative diabetes drugs.

FDA Reviews Incretin Mimetics and Pancreatic Cancer

In March 2013, the FDA announced that it was investigating the entire incretin mimetics class, following the publication of the study in Diabetes that same month. However, the agency has so far been unable to confirm a link between these drugs and pancreatic cancer

What is Pancreatic Cancer?

The pancreas is a digestive organ that produces insulin and glucagon, two metabolic hormones that are involved in regulating blood glucose. The pancreas also produces digestive enzymes that help break down food.

Pancreatic cancer usually spreads rapidly and is rarely detected in its early stages, as the majority of patients do not experience any symptoms early on. In fact, symptoms may not appear until the disease is very advanced, and sugery is no longer an option.

Signs and symptoms of pancreatic cancer may include:

  • Abdominal Pain
  • Bloating
  • Nausea
  • Diarrhea
  • Pale colored stools
  • Dark colored urine
  • Unexplained weight loss
  • Loss of appetite
  • Elevated blood sugar
  • Malaise
  • Jaundice (yellowing of skin and/or eyes)

Did You Develop Pancreatic Cancer While Using Victoza? Our Attorneys Can Help.

You may be entitled to compensation if you or a loved one were diagnosed with pancreatic cancer while using Victoza. To learn how the attorneys at Bernstein Liebhard LLP can help you pursue a Victoza lawsuit, please call (888) 994-5118.

  1. Diabetes (2013) “Marked Expansion of Exocrine and Endocrine Pancreas with Incretin Therapy in Humans with increased Exocrine Pancreas Dysplasia and the potential for Glucagon-producing Neuroendocrine Tumors”
  2. BMJ (2013) “Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed?”
  3. (2012) “Call for Diabetes Drug Ban”
  4. FDA (2013) “FDA Drug Safety Communication: FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes”
Last Modified: April 13, 2016

Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.


Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest

Skip to content